Trulicity (Eli Lilly Italia SPA)


Welcome to the PulseAid listing for the Trulicity drug offered from Eli Lilly Italia SPA. This GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly Italia SPA
NON-PROPRIETARY NAME: Dulaglutide
SUBSTANCE NAME: DULAGLUTIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT
START MARKETING DATE: 2014-11-07
END MARKETING DATE: 0000-00-00


Trulicity HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrulicity from Eli Lilly Italia SPA
LABELER NAME: Eli Lilly Italia SPA
DEA SCHEDULE:
ACTIVE STRENGTH: 0.75(mg/.5mL)
START MARKETING DATE: 2014-11-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54568-433_56b5469a-7f3a-4980-8750-a05826985d59
PRODUCT NDC: 54568-433
APPLICATION NUMBER: BLA125469

Other DULAGLUTIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eli Lilly and CompanyTrulicity
Eli Lilly Italia SPATrulicity